It can limit relapses.
In addition to slowing the progression of the disease, Ocrevus has also been shown to stop relapses (in the trial, it halted the disease in nearly half of RMS patients) and improve symptoms. Many patients in the clinical trial saw reduced pain levels and improved brain function (a.k.a. less brain fog).
It can improve your body’s ability to move.
As MS progresses, walking often becomes more difficult. One of the key markers in the Ocrevus clinical trials was the walk test. Patients taking Orevus reduced the time required to walk 25 feet by 29 percent. In addition to walking ability, researchers studied MS patients ability to move their bodies on Ocrevus, and those scores improved as well.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?